Percutaneous gastrostomy in patients with a ventriculoperitoneal shunt: case series and review

Robert Baird1, Robert Salasidis

  • 1Department of General Surgery, McGill University Health Center, Montreal, Canada.

Insights

Percutaneous endoscopic gastrostomy (PEG) placement is safe for patients with ventriculoperitoneal shunts. This study found no shunt malfunctions or complications, indicating PEG is a viable option for these patients.

Area of Science:

  • Gastroenterology
  • Neurosurgery
  • Medical Devices

Background:

  • Limited data exists on the safety of percutaneous endoscopic gastrostomy (PEG) in patients with ventriculoperitoneal (VP) shunts.
  • VP shunts are crucial for managing cerebrospinal fluid, and their integrity is paramount.

Purpose of the Study:

  • To evaluate the safety and complications of PEG placement in patients with pre-existing VP shunts.
  • To assess the risk of shunt malfunction or related complications following PEG insertion.

Main Methods:

  • Retrospective review of medical records from January 1, 1991, to January 1, 1999.
  • Inclusion criteria: patients with VP shunts who underwent PEG placement.
  • Data collection focused on immediate, short-term, and long-term complications.

Main Results:

  • Six patients with VP shunts underwent PEG placement.
  • No immediate complications related to PEG insertion were observed.
  • One patient experienced pneumonia two months post-PEG; no shunt malfunctions, intra-abdominal issues, or wound infections occurred.
  • No long-term complications involving the VP shunt or PEG were reported.

Conclusions:

  • Percutaneous endoscopic gastrostomy (PEG) placement appears safe in patients with pre-existing ventriculoperitoneal shunts when prophylactic antibiotics are administered.
  • Despite the small sample size, the findings suggest a favorable safety profile for PEG in this specific patient population.
Abstract